Report cover image

Mid-Size Pharmaceuticals Global Market Report 2023 Including: 1) By Drug Development Type: In-House; Outsource 2) By Type: Prescription; Over the Counter 3) By Formulation: Tablets; Capsules; Injectables; Sprays 4) By Application: Cardiovascular Diseases;

Publisher The Business Research Company
Published Sep 21, 2023
Length 175 Pages
SKU # BRC18193175

Description

Mid-Size Pharmaceuticals Global Market Report 2023

Including: 1) By Drug Development Type: In-House; Outsource2) By Type: Prescription; Over the Counter3) By Formulation: Tablets; Capsules; Injectables; Sprays4) By Application: Cardiovascular Diseases; Pain Management; Diabetes; CancerCovering: Baxter International Inc.; Teva Pharmaceutical Industries Ltd.; Otsuka Pharmaceutical Co Ltd.; Arkema Inc.; Astellas Pharma Inc.


Mid-Size Pharmaceuticals Global Market Report 2023 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on mid-size pharmaceuticals market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase
  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia – Ukraine war’s impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.
Description:

Where is the largest and fastest growing market for mid-size pharmaceuticals? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The mid-size pharmaceuticals market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

Scope

Markets Covered:1) By Drug Development Type: In-House; Outsource

2) By Type: Prescription; Over the Counter

3) By Formulation: Tablets; Capsules; Injectables; Sprays; Other Formulations

4) By Application: Cardiovascular Diseases; Pain Management; Diabetes; Cancer; Other Conditions

Companies Mentioned: Baxter International Inc.; Teva Pharmaceutical Industries Ltd.; Otsuka Pharmaceutical Co Ltd.; Arkema Inc.; Astellas Pharma Inc.

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Delivery format: PDF, Word and Excel Data Dashboard.

Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Table of Contents

175 Pages
1. Executive Summary
2. Mid-Size Pharmaceuticals Market Characteristics
3. Mid-Size Pharmaceuticals Market Trends And Strategies
4. Mid-Size Pharmaceuticals Market - Macro Economic Scenario
4.1. Impact Of High Inflation On Online Therapy Services Market
4.2. Ukraine-Russia War Impact On Online Therapy Services Market
4.3. COVID-19 Impact On Online Therapy Services Market
5.1. Global Mid-Size Pharmaceuticals Historic Market Size and Growth, 2017 - 2022, Value ($ Billion)
5.2. Global Mid-Size Pharmaceuticals Forecast Market Size and Growth, 2022 - 2027, 2032F, Value ($ Billion)
5.3. Global Mid-Size Pharmaceuticals Market Drivers and Restraints
5.3.1. Drivers Of The Market
5.3.2. Restraints Of The Market
6. Mid-Size Pharmaceuticals Market Segmentation
6.1. Global Mid-Size Pharmaceuticals Market, Segmentation By Drug Development Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
In-House
Outsource
6.2. Global Mid-Size Pharmaceuticals Market, Segmentation By Type , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Prescription
Over the Counter
6.3. Global Mid-Size Pharmaceuticals Market, Segmentation By Formulation, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Tablets
Capsules
Injectables
Sprays
Other Formulations
6.4. Global Mid-Size Pharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Cardiovascular Diseases
Pain Management
Diabetes
Cancer
Other Conditions
7. Mid-Size Pharmaceuticals Market Regional And Country Analysis
7.1. Global Mid-Size Pharmaceuticals Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
7.2. Global Mid-Size Pharmaceuticals Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
8. Asia-Pacific Mid-Size Pharmaceuticals Market
8.1. Asia-Pacific Mid-Size Pharmaceuticals Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Mid-Size Pharmaceuticals Market, Segmentation By Drug Development Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
8.3. Asia-Pacific Mid-Size Pharmaceuticals Market, Segmentation By Formulation, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
8.4. Asia-Pacific Mid-Size Pharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
9. China Mid-Size Pharmaceuticals Market
9.1. China Mid-Size Pharmaceuticals Market Overview
9.2. China Mid-Size Pharmaceuticals Market, Segmentation By Drug Development Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion
9.3. China Mid-Size Pharmaceuticals Market, Segmentation By Formulation, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion
9.4. China Mid-Size Pharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion
10. India Mid-Size Pharmaceuticals Market
10.1. India Mid-Size Pharmaceuticals Market, Segmentation By Drug Development Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
10.2. India Mid-Size Pharmaceuticals Market, Segmentation By Formulation, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
10.3. India Mid-Size Pharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
11. Japan Mid-Size Pharmaceuticals Market
11.1. Japan Mid-Size Pharmaceuticals Market, Segmentation By Drug Development Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
11.2. Japan Mid-Size Pharmaceuticals Market, Segmentation By Formulation, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
11.3. Japan Mid-Size Pharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
12. Australia Mid-Size Pharmaceuticals Market
12.1. Australia Mid-Size Pharmaceuticals Market, Segmentation By Drug Development Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
12.2. Australia Mid-Size Pharmaceuticals Market, Segmentation By Formulation, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
12.3. Australia Mid-Size Pharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
13. Indonesia Mid-Size Pharmaceuticals Market
13.1. Indonesia Mid-Size Pharmaceuticals Market, Segmentation By Drug Development Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
13.2. Indonesia Mid-Size Pharmaceuticals Market, Segmentation By Formulation, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
13.3. Indonesia Mid-Size Pharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
14. South Korea Mid-Size Pharmaceuticals Market
14.1. South Korea Mid-Size Pharmaceuticals Market, Segmentation By Drug Development Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
14.2. South Korea Mid-Size Pharmaceuticals Market, Segmentation By Formulation, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
14.3. South Korea Mid-Size Pharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
15. Western Europe Mid-Size Pharmaceuticals Market
15.1. Western Europe Mid-Size Pharmaceuticals Market Overview
15.2. Western Europe Mid-Size Pharmaceuticals Market, Segmentation By Drug Development Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
15.3. Western Europe Mid-Size Pharmaceuticals Market, Segmentation By Formulation, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
15.4. Western Europe Mid-Size Pharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
16. UK Mid-Size Pharmaceuticals Market
16.1. UK Mid-Size Pharmaceuticals Market, Segmentation By Drug Development Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
16.2. UK Mid-Size Pharmaceuticals Market, Segmentation By Formulation, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
16.3. UK Mid-Size Pharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
17. Germany Mid-Size Pharmaceuticals Market
17.1. Germany Mid-Size Pharmaceuticals Market, Segmentation By Drug Development Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
17.2. Germany Mid-Size Pharmaceuticals Market, Segmentation By Formulation, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
17.3. Germany Mid-Size Pharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
18. France Mid-Size Pharmaceuticals Market
18.1. France Mid-Size Pharmaceuticals Market, Segmentation By Drug Development Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
18.2. France Mid-Size Pharmaceuticals Market, Segmentation By Formulation, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
18.3. France Mid-Size Pharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
19. Italy Mid-Size Pharmaceuticals Market
19.1. Italy Mid-Size Pharmaceuticals Market, Segmentation By Drug Development Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
19.2. Italy Mid-Size Pharmaceuticals Market, Segmentation By Formulation, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
19.3. Italy Mid-Size Pharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
20. Spain Mid-Size Pharmaceuticals Market
20.1. Spain Mid-Size Pharmaceuticals Market, Segmentation By Drug Development Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
20.2. Spain Mid-Size Pharmaceuticals Market, Segmentation By Formulation, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
20.3. Spain Mid-Size Pharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
21. Eastern Europe Mid-Size Pharmaceuticals Market
21.1. Eastern Europe Mid-Size Pharmaceuticals Market Overview
21.2. Eastern Europe Mid-Size Pharmaceuticals Market, Segmentation By Drug Development Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
21.3. Eastern Europe Mid-Size Pharmaceuticals Market, Segmentation By Formulation, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
21.4. Eastern Europe Mid-Size Pharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
22. Russia Mid-Size Pharmaceuticals Market
22.1. Russia Mid-Size Pharmaceuticals Market, Segmentation By Drug Development Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
22.2. Russia Mid-Size Pharmaceuticals Market, Segmentation By Formulation, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
22.3. Russia Mid-Size Pharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
23. North America Mid-Size Pharmaceuticals Market
23.1. North America Mid-Size Pharmaceuticals Market Overview
23.2. North America Mid-Size Pharmaceuticals Market, Segmentation By Drug Development Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
23.3. North America Mid-Size Pharmaceuticals Market, Segmentation By Formulation, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
23.4. North America Mid-Size Pharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
24. USA Mid-Size Pharmaceuticals Market
24.1. USA Mid-Size Pharmaceuticals Market Overview
24.2. USA Mid-Size Pharmaceuticals Market, Segmentation By Drug Development Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
24.3. USA Mid-Size Pharmaceuticals Market, Segmentation By Formulation, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
24.4. USA Mid-Size Pharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
25. Canada Mid-Size Pharmaceuticals Market
25.1. Canada Mid-Size Pharmaceuticals Market Overview
25.2. Canada Mid-Size Pharmaceuticals Market, Segmentation By Drug Development Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
25.3. Canada Mid-Size Pharmaceuticals Market, Segmentation By Formulation, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
25.4. Canada Mid-Size Pharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
26. South America Mid-Size Pharmaceuticals Market
26.1. South America Mid-Size Pharmaceuticals Market Overview
26.2. South America Mid-Size Pharmaceuticals Market, Segmentation By Drug Development Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
26.3. South America Mid-Size Pharmaceuticals Market, Segmentation By Formulation, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
26.4. South America Mid-Size Pharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
27. Brazil Mid-Size Pharmaceuticals Market
27.1. Brazil Mid-Size Pharmaceuticals Market, Segmentation By Drug Development Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
27.2. Brazil Mid-Size Pharmaceuticals Market, Segmentation By Formulation, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
27.3. Brazil Mid-Size Pharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
28. Middle East Mid-Size Pharmaceuticals Market
28.1. Middle East Mid-Size Pharmaceuticals Market Overview
28.2. Middle East Mid-Size Pharmaceuticals Market, Segmentation By Drug Development Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
28.3. Middle East Mid-Size Pharmaceuticals Market, Segmentation By Formulation, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
28.4. Middle East Mid-Size Pharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
29. Africa Mid-Size Pharmaceuticals Market
29.1. Africa Mid-Size Pharmaceuticals Market Overview
29.2. Africa Mid-Size Pharmaceuticals Market, Segmentation By Drug Development Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
29.3. Africa Mid-Size Pharmaceuticals Market, Segmentation By Formulation, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
29.4. Africa Mid-Size Pharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
30. Mid-Size Pharmaceuticals Market Competitive Landscape And Company Profiles
30.1. Mid-Size Pharmaceuticals Market Competitive Landscape
30.2. Mid-Size Pharmaceuticals Market Company Profiles
30.2.1. Baxter International Inc.
30.2.1.1. Overview
30.2.1.2. Products and Services
30.2.1.3. Strategy
30.2.1.4. Financial Performance
30.2.2. Teva Pharmaceutical Industries Ltd.
30.2.2.1. Overview
30.2.2.2. Products and Services
30.2.2.3. Strategy
30.2.2.4. Financial Performance
30.2.3. Otsuka Pharmaceutical Co Ltd.
30.2.3.1. Overview
30.2.3.2. Products and Services
30.2.3.3. Strategy
30.2.3.4. Financial Performance
30.2.4. Arkema Inc.
30.2.4.1. Overview
30.2.4.2. Products and Services
30.2.4.3. Strategy
30.2.4.4. Financial Performance
30.2.5. Astellas Pharma Inc.
30.2.5.1. Overview
30.2.5.2. Products and Services
30.2.5.3. Strategy
30.2.5.4. Financial Performance
31. Mid-Size Pharmaceuticals Market Other Major And Innovative Companies
31.1. Daiichi Sankyo Co. Ltd.
31.2. Alexion Pharmaceuticals Inc.
31.3. UCB S.A.
31.4. Sun Pharmaceutical Industries Ltd.
31.5. Eisai Co. Ltd.
31.6. Wuxi AppTec co. Ltd.
31.7. Les Laboratoires Servier S.A.
31.8. Hospira Inc.
31.9. Perrigo Co Plc
31.10. Aurobindo Pharma Lmited.
31.11. Cipla Limited
31.12. Hikma Pharmaceuticals
31.13. Endo International plc
31.14. Taisho Pharmaceutical Holdings Co. Ltd.
31.15. BioMarin Pharmaceutical Inc.
32. Global Mid-Size Pharmaceuticals Market Competitive Benchmarking
33. Global Mid-Size Pharmaceuticals Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Mid-Size Pharmaceuticals Market
35. Mid-Size Pharmaceuticals Market Future Outlook and Potential Analysis
35.1 Mid-Size Pharmaceuticals Market In 2027 - Countries Offering Most New Opportunities
35.2 Mid-Size Pharmaceuticals Market In 2027 - Segments Offering Most New Opportunities
35.3 Mid-Size Pharmaceuticals Market In 2027 - Growth Strategies
35.3.1 Market Trend Based Strategies
35.3.2 Competitor Strategies
36. Appendix
36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us